Versant Capital Management’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$351K Buy
15,507
+5,829
+60% +$131K 0.03% 417
2026
Q1
$218K Sell
9,678
-1,742
-15% -$40K 0.02% 556
2025
Q4
$272K Buy
11,420
+3,481
+44% +$86.6K 0.03% 396
2025
Q3
$209K Sell
7,939
-1,012
-11% -$26K 0.03% 461
2025
Q2
$256K Buy
8,951
+2,303
+35% +$61.8K 0.04% 377
2025
Q1
$166K Buy
6,648
+6,208
+1,411% +$148K 0.03% 477
2024
Q4
$9.96K Buy
+440
New +$9.55K ﹤0.01% 1398

Other funds holding FMS

Versant Capital Management's FMS Position: Q2 2026 in Review

Versant Capital Management increased its Fresenius Medical Care (FMS) stake by 60% in Q2 2026, buying an estimated $131K and bringing the position to 15,507 shares worth $351K. The position accounts for 0.03% of the portfolio, ranked #417.

Versant Capital Management first reported a position in FMS in Q4 2024 and has held it in 7 quarters since. 234 funds tracked by Wall St. Rank hold FMS as of Q2 2026.

  • Versant Capital Management held 15,507 shares of Fresenius Medical Care worth $351K as of Q2 2026.
  • Versant Capital Management bought 5,829 Fresenius Medical Care shares in Q2 2026, an estimated $131K.
  • Fresenius Medical Care made up 0.03% of Versant Capital Management's portfolio in Q2 2026, its #417 holding.
  • Versant Capital Management first reported a position in Fresenius Medical Care in Q4 2024 and has held it in 7 quarters since.
  • 234 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.